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The Neurospora crmsa plasma membrane H+-ATP- 
ase is inactivated by the periodate-oxidized nucleo- 
tides, oATP,  oADP, and oAMP, with oAMP the most 
effective. Inhibition of the ATPase is essentially irre- 
versible, because Sephadex G-SO column chromatog- 
raphy of the oAMP-treated ATPase does not result  in 
a  reversal of the inhibition. Inhibition of the ATPase 
by  oAMP is protected against by the H+-ATPase sub- 
strate ATP, the product ADP, and the competitive 
inhibitors  TNP (2’,3’-0-(2,4,6-trinitrocyclohexadien- 
y1idine)-ATP and TNP-ADP, suggesting that oAMP 
inhibition occurs at the nucleotide binding site of the 
enzyme. The rate of inactivation of the ATPase by 
oAMP is only slightly affected by EDTA, indicating 
that  the oAMP interaction  with  the nucleotide binding 
site of the H+-ATPase occurs in the absence of a diva- 
lent cation. The protection against oAMP inhibition by 
ADP is likewise unaffected by  EDTA. The inhibition 
of the ATPase by  oAMP is absolutely dependent on the 
presence of acidic phospholipids or acidic lysophospho- 
lipids known to be required  for H+-ATPase activity, 
suggesting that these lipids either  aid in the  formation 
of the nucleotide binding  site or render  it accessible. 
Incubation of the ATPase with Mg2+ plus vanadate, 
which locks the enzyme in a conformation resembling 
the  transition  state of the enzyme dephosphorylation 
reaction, completely protects against inhibition by 
oAMP, suggesting that in this  transition  state confor- 
mation the nucleotide site  either does not exist, or is 
inaccessible to oAMP. Labeling studies  with [‘“C] 
oAMP indicate that  the incorporation of 1 mol  of  oAMP 
is sufficient to cause complete inactivation of the ATP- 
ase. 
The aspartyl phosphate intermediate family of transport 
ATPases includes the Na+/K+-ATPase of animal cell plasma 
membranes (l), the Ca2+-ATPase of sarcoplasmic reticulum 
(2,3),  the K+/H+-ATPase of gastric mucosal membranes (41, 
the K+-ATPase of the plasma membrane of Escherichia coli 
( 5 ) ,  and the H+-ATPases of fungal (6, 7 )  and  plant (8) plasma 
membranes. In  the last decade, these enzymes have  been the 
subject of intensive biochemical, kinetic, and  structure-func- 
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tion  studies that have yielded a wealth of information regard- 
ing their  structure  and mechanism of catalysis (1, 2,  6, 7 ) .  In 
the last few years, the genes for most of these enzymes have 
been cloned and sequenced (9-la), and deductions of the 
amino acid sequences of these enzymes based on the gene 
sequences have revealed that  the overall sequence similarity 
is significant and  that  the predicted secondary structures of 
most of these enzymes are  quite similar with respect to  the 
positions of the putative  transmembrane regions and  those 
involved in ATP binding and phosphorylation (1). Such in- 
formation has led to a prevalent notion in the  transport field 
that these ATPases may have evolved from a common ances- 
tor. For this and other reasons, it has been proposed that 
although there  are  variations with respect to  the ions trans- 
ported, the basic mechanisms of catalysis of these enzymes 
may be similar (19, 20). It is thus reasonable to expect that 
any biochemical motif observed in one of these ATPases may 
be conservatively applicable to other members of this family 
of transport enzymes. 
With this in mind, this laboratory has been involved in 
elucidation of the mechanism of catalysis of the Neurospora 
crmsa plasma membrane H+-ATPase.  Attempts toward such 
a goal are being made by both biophysical and chemical 
approaches to  the elucidation of the  structural organization 
of the ATPase. Circular dichroism studies have established 
the secondary structure  characteristics of the H+-ATPase  and 
revealed marked similarity in secondary structure with the 
related Na+/K+-  and  Ca2+-ATPases (21). These  studies also 
indicated that during nucleotide binding and catalysis no 
major changes occur in the secondary structure of the enzyme, 
which has also been observed for the Ca*+-ATPase (22-24) 
and  the Na+/K+-ATPase (25). Another approach being un- 
dertaken is the identification of essential residues involved in 
substrate binding and catalysis in  the H+-ATPase by the well 
established methods of chemical modification of essential 
residues (26)’ and affinity labeling of the active site of the 
ATPase, To facilitate these efforts we have recently developed 
the protein chemistry methodology necessary for cleavage of 
the H+-ATPase  and the purification of peptides from all parts 
of the molecule, including the refractory hydrophobic sectors 
(27, 28). The availability of such methodology is crucial for 
the identification of key residues with a high degree  of cer- 
tainty. 
The periodate-oxidized nucleotides, oATP,’ oADP, and 
oAMP, have been used extensively for affinity labeling of a 
number of nucleotide binding proteins (29-37). These com- 
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pounds have the advantage of being very similar to  the  parent 
nucleotides in that they  contain an unperturbed  purine  ring 
and  the appropriate number of phosphoryl groups. The only 
part  that is modified is the ribose moiety, and many nucleotide 
binding proteins are believed to tolerate ribose modifications 
(36). In this paper, we provide evidence for a functional 
interaction of these compounds with the Neurospora plasma 
membrane H'-ATPase which leads to irreversible inhibition 
and is protected by substrate  and  substrate analogs. We also 
demonstrate that nucleotide binding does not require the 
presence of a divalent cation, that acidic phospholipids are 
involved in nucleotide binding, that  the nucleotide binding 
site is unavailable in the transition state of the enzyme 
dephosphorylation reaction, and  that inhibition of the enzyme 
is achieved when 1 mol  of nucleotide interacts with 1 mol of 
H'-ATPase monomer. These studies shed significant new 
light on certain aspects of the catalytic mechanism of the H'- 
ATPase and are an important prerequisite for future work 
aimed at  the identification of key amino acid residues in  the 
active site of this  transport enzyme. 
EXPERIMENTAL PROCEDURES 
Materials-The sources of most of the materials used have been 
described before (38). [14C]AMP  was obtained from ICN Radiochem- 
icals. Periodate-oxidized nucleotides (oATP, oADP, and oAMP), L -  
a-lysophosphatidylglycerol, and L-cu-lysophosphatidylcholine were 
purchased from Sigma. Glycerol was obtained from Fisher. 
Purification of the H+-ATPase-The Neurospora plasma mem- 
brane ATPase was isolated according to  Smith  and Scarborough (38, 
39) with the minor modification that  the cell lysis was achieved by 
100 passes in a Plexiglas homogenizer instead of 50. The glycerol 
gradient-isolated ATPase was centrifuged at 12,000 rpm (17,400 X g) 
for 20 min at 4 "C to remove the particulates that develop upon 
storage. The clear supernatant fluid containing the ATPase was then 
further purified by  gel filtration (21) on a  Sepharose CL-4B column 
(2.5 x 90 cm) equilibrated with buffer containing 30% (w/v) glycerol, 
50 mM HEPES  (pH 6.9 with NaOH),  and 2 pg/ml chymostatin. The 
fractions containing the coincident ATPase and protein peaks were 
then pooled and concentrated to 0.5-1.0  mg  of protein/ml using RCF- 
ConFilt hollow-fiber bundles (Mr cutoff 6,000; Biomolecular Dynam- 
ics). The concentrate was then centrifuged at 12,000 rpm (17,400 X 
g)  for 15 min at  4 "C to remove the particulates that develop during 
concentration. The clear solution of the essentially detergent-free 
ATPase was then divided into aliquots and stored at  "20 "C. For 
unknown reasons, the efficiency of periodate-oxidized nucleotide 
inactivation of the H+-ATPase increases with time  after purification 
of the enzyme. Therefore, the purified H+-ATPase  preparation was 
usually stored at "20 'C, whereupon it did not solidify, for 10-14 
days prior to use in the inactivation experiments. The specific activity 
of the ATPase  preparation did not change during this period. 
Assay of ATPase Actiuity-The ATPase activity was measured as 
described by Smith  and Scarborough (38) with the exception that  the 
Folch fraction I was added as a suspension in 0.3% (w/v) sodium 
deoxycholate. The specific activities of the enzyme preparation were 
in the range of  15-20 pmol of  Pi  min"  mg" protein. 
Synthesis of p4CloAMP-The synthesis of the dialdehyde deriva- 
tive of AMP  was carried out according to  the method of Esterbrook- 
Smith (37) as modified by Evans et al. (35). The reaction was 
performed in the dark at  4 "C. To  the ["CIAMP (25 pCi, 53 mCi/ 
mmol) was added a 200-fold excess of AMP in  a volume of 0.9 ml, 
and  the pH adjusted to 7.0 with NaOH. The reaction was initiated 
by the addition of sodium periodate (pH 7.0 with NaOH) in a 2:1 
molar excess over the AMP and  the reaction allowed to proceed for 
1 h. The reaction was terminated by adding a 2-fold molar excess of 
ethane-l,a-diol over the periodate. The analogue was then purified 
from the reaction products by chromatography on  a column of Seph- 
adex G-10 (1.5 x 70 cm) equilibrated in distilled water, monitoring 
fractions at  259 nm. The iodine-containing fractions were determined 
as described (29), and the peak fractions at 259 nm that did not 
contain iodine were pooled, lyophilized, and stored at -80 "C. [l4CC] 
oAMP concentrations were calculated on the basis of an extinction 
coefficient of 14.9 cm" mM" for oAMP at  259  nm (37). Thin layer 
chromatography on cellulose plates  run  in tert-amyl a1cohol:formic 
acid:water (3:2:1; v/v/v) showed that  the purified ['4C]oAMP behaved 
the same as  the pure nonradioactive commercial product. The final 
specific activity of the preparation was  605 cpmfnmol as determined 
by liquid scintillation counting in the scintillation mixture of Patter- 
son and Greene (40). 
Oxidized Nucleotide Treatment of the H+-ATPase-Typical reac- 
tion mixtures  contained 2.5-5.0 p~ ATPase in buffer containing 30% 
(w/v) glycerol, 50 mM HEPES (pH 6.9 with NaOH), and 10 p1 of 
bovine brain  extract suspension (Folch fraction I, 5 mg/ml in 0.3% 
sodium deoxycholate) in a final volume of  100-200 p l  at room tem- 
perature. The reactions were initiated by the addition of the oxidized 
nucleotide at the indicated concentration, and 5-pl aliquots were 
removed at various times and assayed for ATPase activity as de- 
scribed above. In  experiments where the effect of lysophosphatides 
was tested, the lipids were added at a  final  concentration of  250 p ~ ,  
assuming molecular masses of  520 and 539 daltons for lysophospha- 
tidylglycerol and lysophosphatidylcholine, respectively. In most of 
the experiments, control reactions were carried out  in identical fash- 
ion without the addition of an oxidized nucleotide, and  the inhibition 
data expressed as a  percent of that control. There was essentially no 
loss of activity in such controls. 
Stoichiometry of Labeling of the H+-ATPase with f4C]oAMP- 
Aliquots containing 100 pg of purified ATPase were incubated as 
described above in the presence of 5 mM ["CIoAMP in  a reaction 
volume of  200 $1, and  the reactions were  allowed to proceed at  room 
temperature for 0-10 min. At different times, 5-pl aliquots were 
removed and assayed for activity while the remainder was  mixed with 
10 pl of 0.5 M N&H4 (in 0.1 N NaOH) and allowed to  stand for 25 
min on ice. The protein was then precipitated with trichloroacetic 
acid following incubation with deoxycholate according to  the method 
of Bensadoun and Weinstein (41). The precipitates were washed by 
suspension in  4 ml of 6% trichloroacetic acid followed  by centrifuga- 
tion at 2500 rpm for 30 min at room temperature two times. The 
washed precipitates were then dissolved in 0.5 ml of 0.1 M MES  (pH 
6.9 with Tris) containing 0.05%  (w/v) SDS,  and the radioactivity in 
the samples determined as described above. 
Protein Determination-Protein was determined by the method of 
Lowry et al. (42) after precipitation of the protein by the deoxycho- 
late-trichloroacetic acid method of Bensadoun and Weinstein (41) 
using bovine serum albumin as a  standard. 
RESULTS 
Fig. 1 shows the results obtained when the purified H+- 
ATPase was incubated with oATP, oADP, or oAMP for 
varying times and assayed for ATPase activity. All three 
periodate-oxidized nucleotides inactivate the H'-ATPase in 
a  time-dependent  manner at a  concentration of 5 mM. Oxi- 
dized AMP is the most effective analog tested, rapidly inac- 
tivating the enzyme in only a few minutes. Oxidized ATP and 
ADP were less effective. Increasing the concentration of 
oAMP in increments from 1 to 6 mM gave progressively 
increasing rates of inactivation, but semi-log plots of the 
inactivation time courses were nonlinear at all  concentrations 
of oAMP  tested  (not  shown), precluding the accurate esti- 
FIG. 1. Inactivation of the Neurospora plasma membrane 
H+-ATPase by oxidized nucleotides. The enzyme was incubated 
with 5 mM oATP (0), 5 mM oADP (e), or 5 mM oAMP (A), and 
samples were taken  at different times and assayed for residual activ- 
ity. 
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FIG. 2. Effect of various nucleotides on inactivation of the 
H+-ATPase by oAMP. A, the enzyme was incubated with 5 mM 
oAMP in the absence (0) or presence of 10 mM ATP (0) or 5 mM 
ADP (m), and samples were taken  at different time intervals and 
assayed for residual ATPase activity. B, the enzyme was incubated 
with 5 mM oAMP in the absence (0) or presence of 0.5 mM TNP- 
ATP (m) or 0.5 mM TNP-ADP (O), and samples were taken at 
different times and assayed for residual activity. 
mation of inhibition rate constants. Although not shown, 
when the oAMP-inhibited ATPase was subjected to Sephadex 
G-50 column chromatography to remove the excess nucleotide 
the inhibition remained, indicating that  the H+-ATPase  in- 
hibition reaction is essentially irreversible. When the native 
and oAMP-modified H+-ATPase were electrophoresed in so- 
dium dodecyl sulfate-polyacrylamide gel electrophoresis gels 
under reducing conditions, no species larger than 100 kDa 
were observed, indicating that  the inhibition is not due to 
intermolecular cross-linking of the H+-ATPase molecules. 
Fig. 2A shows the effects of the H+-ATPase  substrate, ATP, 
and product, ADP, on the oAMP inhibition reaction. Inacti- 
vation of the ATPase by oAMP is completely protected 
against by including ATP (10 mM) or ADP (5 mM) during the 
inactivation reactions. Fig. 2B shows the effects of TNP-ATP 
and  TNP-ADP, which are competitive inhibitors of the H+- 
ATPase with apparent Ki values of approximately 65 and 250 
PM, respectively,3 on the oAMP inhibition reaction. The in- 
clusion of 0.5 mM TNP-ATP completely protects  against the 
inactivation, and 0.5 mM TNP-ADP protects the enzyme 
partially. The addition of the TNP-nucleotides at  the concen- 
trations indicated without oAMP did not affect subsequent 
assays of the enzyme activity. 
The experiments presented thus far were carried out  in  the 
absence of added M$+, suggesting that a divalent cation is 
not required for the oxidized nucleotide inhibition reaction. 
However, the presence of traces of M$+ or other divalent 
cations  as  contaminants  in the various reagents used in these 
A. P. Bidwai and G.  A. Scarborough, unpublished observations. 
experiments is possible. Therefore, to clarify this  important 
issue, the effect of EDTA on oAMP inactivation of the  H+- 
ATPase was investigated. Fig. 3 shows the effect of EDTA on 
inactivation of the ATPase by oAMP and protection  against 
inactivation by ADP. In  the presence of 2 mM EDTA, the 
inactivation rate observed with oAMP is only slightly reduced, 
and  the addition of 5 mM ADP completely protects  against 
this inactivation, indicating that neither the oAMP inhibition 
nor protection by ADP require a divalent cation. 
We have demonstrated before that  the H+-ATPase  in  de- 
tergent-washed membranes requires acidic phospholipids for 
activity (43), and more recent experience with the purified 
H+-ATPase  indicates an absolute requirement for acidic phos- 
pholipids for activity. Moreover, we have recently reported 
that  the acidic phospholipid requirement can be satisfied by 
acidic lysophospholipids, including lysophosphatidylglycerol 
(21). For  this reason, the effects of several pertinent lipids on 
the oAMP inhibition reaction were investigated. The results 
(Fig. 4), show that  in  the absence of acidic phospholipids from 
bovine brain (Folch fraction I), which is normally used to 
satisfy the acidic phospholipid requirement of the H+-ATPase 
in our  ATPase assays, oAMP does not  inhibit the ATPase. 
The addition of Folch fraction I (0.05%, w/v) induces a rapid 
inactivation of ATPase activity. The addition of Folch frac- 
tion I alone in such an experiment does not inhibit the 
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FIG. 3. Effect of EDTA on oAMP inactivation of the H+- 
ATPase and protection by ADP. The enzyme was incubated with 
5 mM oAMP or 5 mM oAMP plus 5 mM ADP in the presence or 
absence of 2 mM EDTA, and samples were taken  at various times 
and assayed for residual ATPase activity. oAMP alone (A); oAMP 
plus EDTA (0); oAMP plus ADP (A); and oAMP plus ADP plus 
EDTA (0). 
TIME (rnin) 
FIG. 4. Effect of lipids on inactivation of the H+-ATPase by 
oAMP. The enzyme was incubated in the presence of oAMP for 3 
min. At this time, the incubations were brought to either 0.05% (w/ 
v) Folch fraction I (m), 250 NM lysophosphatidylglycerol (A), or 250 
PM lysophosphatidylcholine (0). The reactions were  allowed to pro- 
ceed for the indicated times, and samples were  removed and assayed 
for residual ATPase activity. 
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FIG. 5. Effect of MgS04 and sodium vanadate alone and in 
combination on oAMP inactivation of the H+-ATPase. The 
enzyme was incubated with 5 mM oAMP alone (O), or in the presence 
of 1 mM MgS04 (O), 0.1 mM Na3V04 (A), or 1 mM MgS04 plus 0.1 
mM Na3V04 (m) for 3 min. At that time, the reactions were brought 
to 0.025% (w/v) Folch fraction I. The Folch fraction I concentration 
was decreased by 50% compared to  the other  experiments described, 
in order to prevent  precipitation of the lipids by  MgSO,. 
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FIG. 6. Stoichiometry of labeling of the H+-ATPase by [14C] 
oAMP. The ATPase was incubated for varying times with 5 mM 
[“CIoAMP (605 cpm/nmol), and  the residual activity and ATPase 
labeling were determined as described under “Experimental Proce- 
dures.” 
ATPase  in subsequent assay, indicating that  the combination 
of oAMP and acidic phospholipids is required for inactivation 
(not shown). When Folch fraction  I is replaced by lysophos- 
phatidylglycerol, which also supports  ATPase activity, inac- 
tivation is observed (Fig. 4). On the other  hand, the addition 
of lysophosphatidylcholine, a lysolipid that does not  support 
ATPase activity, to  the incubation mixture does not result in 
any oAMP inactivation of the enzyme during the time course 
of these experiments. 
As has been explained previously, the combination of the 
H+-ATPase ligands, Mg2+ plus vanadate, is thought to lock 
the enzyme in a  state resembling the transition  state of the 
enzyme dephosphorylation reaction (44). It was therefore of 
interest to determine whether or not oAMP is capable of 
inactivating the H+-ATPase when it is locked in this  transi- 
tion  state. Fig. 5 shows the effect of  M$+ and  vanadate, alone 
and in combination, on oAMP inactivation of the H+-ATPase. 
The addition of  MgSO, (1 mM), or  Na3V04 (100 FM) alone do 
not significantly affect the  rate of oAMP inactivation of the 
enzyme. However, in the presence of  M$+ and vanadate 
together, oAMP is unable to inhibit the enzyme. 
Fig. 6 shows the combined results of several experiments in 
which the H+-ATPase was inhibited to varying degrees by 
[‘4C]oAMP by incubating for increasing time periods and 
then assessed for the  extent of labeling, as described under 
“Experimental Procedures.” The results indicate that the 
extent of incorporation of label parallels the extent of inacti- 
vation, with complete inactivation being obtained when ap- 
proximately 1 mol of nucleotide has been incorporated per 
mol of 100,000-dalton monomer. 
DISCUSSION 
The results presented demonstrate  interactions of the di- 
aldehyde analogs oATP, oADP, and oAMP with the Neuro- 
spora plasma membrane H+-ATPase. The interaction of these 
nucleotides with the ATPase  results in a time- and concen- 
tration-dependent, irreversible inactivation of the ATPase. 
Semi-log plots of the time courses of the oAMP inactivation 
reactions were nonlinear at all concentrations of the nucleo- 
tide  tested, precluding the accurate  estimation of inhibition 
rate  constants. The reasons for this nonlinearity are presently 
unknown. It is  not due to  the breakdown of the oAMP during 
the inactivation process, as  the addition of acidic phospho- 
lipids, which are required for the inhibition reaction, at in- 
creasing times  after the addition of oAMP resulted in identical 
rates of inactivation (data not shown). The nonlinearity is 
also not due to diminution of the oAMP concentration  as  a 
result of interaction with amino groups of the added acidic 
phospholipids, as  the characteristics of the nonlinearity did 
not vary as a function of the acidic phospholipid concentra- 
tion. Furthermore, the nonlinearity is also seen when lyso- 
phosphatidylglycerol, which would not be expected to  interact 
with oAMP, is used to satisfy the acidic phospholipid require- 
ment. It is possible that  the nonlinearity is related to the 
aging process required for the H+-ATPase to become effi- 
ciently inhibited by  oxidized nucleotides (see “Experimental 
Procedures”). Or, because the H+-ATPase is a hexamer as 
isolated (45), it is possible that  the nonlinearity is  the result 
of monomer-monomer interactions in the hexamers. Or fi- 
nally, the nonlinearity may  be an intrinsic  characteristic of 
the interaction of oxidized nucleotides with certain enzymes, 
as similar nonlinear  inactivation kinetics have been observed 
for phosphofructokinase (32), and  the FoF,-ATPase (34). In 
any case, as  the rest of the results  presented in this commu- 
nication clearly show, the atypical kinetics of the oAMP 
inhibition reaction do not preclude the usefulness of oAMP 
as  a specific, irreversible inhibitor of the H+-ATPase. 
Regarding the  nature of the inhibitor reaction, periodate- 
oxidized nucleotides are normally thought to interact with the 
amino group of lysine residues in enzymes, resulting in the 
formation of a Schiff base that requires NaBH4 reduction in 
order to obtain irreversible inhibition. However, Sephadex 
column chromatography experiments indicate that oAMP 
inhibition of the Neurospora H+-ATPase is irreversible with- 
out reduction by NaBH,. Similar irreversible inactivation by 
oxidized nucleotides has been observed for the beef heart 
mitochondrial ATPase (34), the Na+-ATPase from Achole- 
plasma laidlawii (31), and phosphofructokinase (32) and has 
been suggested to be due to  the formation of morpholino-type 
adducts between the oxidized nucleotide and  the enzyme (32). 
Oxidized AMP inactivated the ATPase with the highest 
rate of the nucleotides tried, followed by oADP and then 
oATP. This would appear to indicate that  the affinity of the 
enzyme for the nucleotides is in the order oAMP > oADP > 
oATP. However, ADP is a fairly strong competitive inhibitor 
of the ATPase with an apparent K,  of about 200 PM (44), 
whereas AMP is a relatively poor competitive inhibitor of the 
ATPase with an apparent Ki of about 20 mM.3 It is thus 
interesting that oAMP should have such a high apparent 
affinity for the  H+-ATPase compared to oADP. A reasonable 
explanation for such a result is the suggestion put forward for 
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the inactivation of the mitochondrial FoF1-ATPase by oAMP, 
that due to cleavage of the ribose, the molecule can undergo 
some  degree of flexing and  thus take on the molecular dimen- 
sions of ADP (34). It is also possible that  the nucleotides 
interact with the ATPase with different affinities in the 
presence and absence of a divalent cation. 
An important criterion for the establishment of a compound 
as  an affinity analog is the ability of substrates, products, and 
competitive inhibitors to protect  against inactivation by that 
compound. The results of the experiments shown in Fig. 2 
indicate that oAMP inhibition of the  H+-ATPase is effectively 
protected against by substrate and product levels of ATP and 
ADP, and even lower levels of the relatively high affinity 
competitive inhibitors, TNP-ATP  and  TNP-ADP. Whereas 
we have  previously presented strong evidence for the induc- 
tion of substantial H+-ATPase conformational changes by 
MgATP, MgADP, and Mg2+ plus vanadate (44), little evidence 
has been obtained indicating H+-ATPase conformational 
changes induced by nucleotides in  the absence of a divalent 
cation. Therefore, since protection against oAMP inhibition 
by ATP and ADP clearly occurs in the absence of a divalent 
cation, the possibility that ATP and ADP protect the  H+- 
ATPase against oAMP inhibition by inducing long range H+- 
ATPase conformational changes is considered less likely than 
direct competition between oAMP and  ATP, ADP, and  the 
TNP-nucleotides, for the H+-ATPase nucleotide binding site. 
Thus, the results of the ATP, ADP, and TNP-nucleotide 
protection experiments strongly support the idea that oAMP 
inhibits the H+-ATPase by an irreversible interaction at  its 
nucleotide binding site. Obviously, the fact that oAMP is  a 
nucleotide analog gives additional  strong  support o  this idea. 
We have previously shown that 100-kDa monomers of the 
H+-ATPase  are fully functional (46), and, in our hands,  plots 
of the H'-ATPase activity versus the concentration of 
MgATP show no sigmoidicity,3 indicating that  the  H+- 
ATPase monomers probably contain  a single nucleotide bind- 
ing site. Moreover, as will  be further discussed below, the  H+- 
ATPase labeling studies with ['4C]oAMP strongly support 
this  contention. If so, assuming that oAMP inhibition does 
occur by interaction at  this nucleotide binding site  as reasoned 
above, the facts that oAMP inhibition and  ATP, ADP, and 
TNP-nucleotide protection against oAMP inhibition occur in 
the absence of a divalent cation is evidence that nucleotide 
binding to  the H+-ATPase  can  take place in the absence of a 
divalent  cation. Thus  the implications from kinetic experi- 
ments that  the "true  substrate" of the ATPase is MgATP (7, 
47) should not be taken  to indicate that nucleotide binding 
cannot occur in the absence of a divalent cation. We have 
recently reached the same conclusion on the basis of nucleo- 
tide protection against  inhibition of the H+-ATPase by dieth- 
ylpyrocarbonate,' and convincing evidence for the interaction 
of nucleotides with the nucleotide binding site in the absence 
of a divalent cation has also been presented for both the Na+/ 
K+-ATPase  and Ca2+-ATPase (48-50). Pertinent  in  this  re- 
gard, electron paramagnetic resonance studies on the Na+/K+- 
ATPase by Grisham and coworkers (51-54) indicate that  the 
spectra of the enzyme-Mn2+, enzyme-ATP, and enzyme- 
Mn*+-ATP complexes are significantly different than those 
obtained for Mn2+-ATP.  For enzymes that use M2'-ATP as 
the  substrate  and form enzyme-ATP-M2+ bridge complexes, 
the  EPR spectrum of the  ternary complex is usually similar 
to  that of the binary complex between M2+ and ATP (51). 
Although it has been clear for some time now that  the H'- 
ATPase absolutely requires acidic phospholipids or acidic 
lysophospholipids for activity (21, 43), the precise role of 
these lipids and the stage of the catalytic cycle in which they 
are  important  has been totally unknown. The acidic phospho- 
lipid/lysophospholipid requirement for inhibition of the  H+- 
ATPase by oAMP (Fig. 4) sheds significant light on this 
interesting question. Because oAMP binding to the H+- 
ATPase nucleotide binding site  appears to be the only prereq- 
uisite for inhibition of the ATPase, the fact that  the acidic 
phospholipids or lysophospholipids are required for oAMP 
inhibition can be interpreted to mean that the nucleotide 
binding site is not available in  the absence of acidic phospho- 
lipids or lysophospholipids. One explanation of this phenom- 
enon could be that  the complete nucleotide binding site  exists 
but is occluded in the absence of acidic phospholipids or 
lysophospholipids, as for example in an interdomain cleft that 
requires the specific lipids for opening and exposure of the 
nucleotide binding site. Such interdomain movements are 
more likely than major structural rearrangements in the 
ATPase molecule, as we have recently shown by circular 
dichroism measurements that significant changes in second- 
ary  structure do not occur upon activation of the  H+-ATPase 
by the acidic lysophosphatide, lysophosphatidylglycerol (21). 
Alternatively, it may be that the binding site, per se, is 
incomplete until the acidic lipid has bound. In  any case, these 
results tend to define nucleotide binding as a step in the 
catalytic cycle of the Neurospora Hf-ATPase  that requires 
acidic phospholipids or lysophospholipids. Acidic phospho- 
lipid requirements have also been described for the Na'/K+- 
ATPase  (55), the plasma membrane H+-ATPase from Schi- 
zosaccharomyces cereuisiae (56))  and the Ca2+-ATPase of 
erythrocytes (57). It is possible that nucleotide binding to 
these enzymes is the  step requiring acidic phospholipids as 
well. 
The marked protection of the H'-ATPase against oAMP 
inactivation by M$+ plus vanadate (Fig. 5) also bears in an 
important way on the catalytic mechanism of the H'-ATPase. 
We have previously presented a reasonable argument, based 
on the effects of a variety of H+-ATPase ligands on the 
sensitivity of the enzyme to degradation by trypsin, that  the 
combination of H+-ATPase ligands, M$+ plus vanadate, locks 
the molecule in  a conformation resembling the transition state 
of the enzyme dephosphorylation reaction (44). Because the 
experiments of Fig. 5 were carried out  in the presence of acidic 
phospholipids, it  is likely that  the nucleotide binding site was 
functional in  these experiments. Therefore, the most straight- 
forward interpretation of the profound M%f plus vanadate 
protection of the  H+-ATPase against  inactivation by oAMP 
is that the nucleotide binding site is unavailable when 
the H+-ATPase is in the transition state of the enzyme 
dephosphorylation reaction. Whereas conformational re- 
arrangements in the H+-ATPase molecule that totally  disrupt 
the nucleotide binding site at  this stage of the catalytic cycle 
cannot be ruled out, we prefer a more biochemically orthodox 
interpretation in which the nucleotide binding site is simply 
occluded at this  step  in the cycle  by virtue of its being buried 
in a cleft between two or more domains of the molecule, by 
analogy with numerous other phosphoryl transfer enzymes 
for which the  structures  are known (58). In support of this 
notion, the circular dichroism studies mentioned above also 
showed that major changes in  the secondary structure com- 
position of the H+-ATPase do not occur when the acidic 
lysophosphatide-activated enzyme proceeds from its unli- 
ganded conformation to  the conformation it assumes during 
the enzyme dephosphorylation reaction (21). The idea that 
the H+-ATPase may undergo hinge-bending interdomain 
movements during the catalytic cycle  was also mentioned in 
that paper and  has been elaborated upon elsewhere (19, 20). 
It should be mentioned that  the  data  are also consistent with 
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a simple competitive block  of oAMP binding to  the active site 
by M$+ plus vanadate. 
Finally, our results on the stoichiometry of labeling of the 
H+-ATPase indicating the  attachment of 1 mol of oAMP/mol 
of H+-ATPase monomer (Fig. 6) are important for at least 
two reasons. First,  this outcome supports  further the conten- 
tion presented earlier that monomers of the H+-ATPase have 
a single nucleotide binding site. Second, H+-ATPase labeling 
with a stoichiometry of one is the simplest possible starting 
point for identification of the residue(s) in the H+-ATPase 
nucleotide binding site that  are modified  by oAMP. This, and 
our recently developed  methodology for quantitatively frag- 
menting the H+-ATPase  and isolating the peptides produced 
(27, 28) augur that information regarding the identity of one 
or more residues in the H+-ATPase nucleotide binding site 
may  become available in the near  future. 
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